SI1259512T1 - Pteridine compounds for the treatment of psoriasis - Google Patents

Pteridine compounds for the treatment of psoriasis

Info

Publication number
SI1259512T1
SI1259512T1 SI200130043T SI200130043T SI1259512T1 SI 1259512 T1 SI1259512 T1 SI 1259512T1 SI 200130043 T SI200130043 T SI 200130043T SI 200130043 T SI200130043 T SI 200130043T SI 1259512 T1 SI1259512 T1 SI 1259512T1
Authority
SI
Slovenia
Prior art keywords
psoriasis
treatment
pteridine compounds
pteridine
compounds
Prior art date
Application number
SI200130043T
Other languages
Slovenian (sl)
Inventor
Roger Bonnert
Stewart Gardiner
Fraser Hunt
Iain Walters
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0004128A external-priority patent/GB2359551A/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SI1259512T1 publication Critical patent/SI1259512T1/en

Links

SI200130043T 2000-02-23 2001-02-20 Pteridine compounds for the treatment of psoriasis SI1259512T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0004128A GB2359551A (en) 2000-02-23 2000-02-23 Pharmaceutically active pyrimidine derivatives
PCT/SE2001/000374 WO2001062758A1 (en) 2000-02-23 2001-02-20 Pteridine compounds for the treatment of psoriasis
EP01906493A EP1259512B1 (en) 2000-02-23 2001-02-20 Pteridine compounds for the treatment of psoriasis

Publications (1)

Publication Number Publication Date
SI1259512T1 true SI1259512T1 (en) 2004-02-29

Family

ID=31889423

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130043T SI1259512T1 (en) 2000-02-23 2001-02-20 Pteridine compounds for the treatment of psoriasis

Country Status (1)

Country Link
SI (1) SI1259512T1 (en)

Similar Documents

Publication Publication Date Title
IL151132A0 (en) Pteridine compounds for the treatment of psoriasis
AU6048201A (en) Quinazoline derivatives for the treatment of tumours
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
HUP0202807A3 (en) Compounds for the treatment of ischemia
IL150742A0 (en) Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
ZA200305691B (en) The use of substituted azetidione compounds for the treatment of sitosterolemia
EP1274444A4 (en) Compounds for the treatment of psychiatric or substance abuse disorders
IL162485A0 (en) Compounds for the treatment of inflammatory disorders
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
EP1442062A4 (en) Methods for the treatment of carcinoma
AU2000258650A1 (en) 2-piperidone compounds for the treatment of cancer
AU2001290165A8 (en) Components of canola for the treatment of cancer
AU8322401A (en) Indole compounds useful for the treatment of cancer
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
HRP20020729A2 (en) Treatment of psoriasis
ZA200110539B (en) Oxazinocarbazoles for the treatment of CNS diseases.
PT1698338E (en) S-methyl-dihydro-ziprasidone for the treatment of schizophrenia
AU2001261324A1 (en) Psoriasis treatment
HK1043938A1 (en) Composition for the treatment of psoriasis
HRP20020262A2 (en) Substituted pyrroles as antiproliferative agents for the treatment of cancer
SI1259512T1 (en) Pteridine compounds for the treatment of psoriasis
GB9906993D0 (en) Psoriasis
PL354980A1 (en) Use dexrazoxane for treating psoriasis